Secukinumab for patients with plaque psoriasis affected by multiple sclerosis: a mini-review with a representative case report

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e110-e112. doi: 10.1111/jdv.16035. Epub 2019 Nov 14.

Authors

M Venturini¹, A Zanca¹, A Venturuzzo¹, M Filippini², M Frassi², A Tincani², P G Calzavara-Pinton¹

Affiliations

¹ Dermatology Department, University of Brescia, ASST Spedali Civili Hospital, Brescia, Italy.
² Rheumatology and Clinical Immunology Unit, University of Brescia, ASST Spedali Civili Hospital, Brescia, Italy.

PMID: 31667904
DOI: 10.1111/jdv.16035

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Antibodies, Monoclonal, Humanized / therapeutic use*
Female
Humans
Middle Aged
Multiple Sclerosis / drug therapy*
Psoriasis / drug therapy*
Severity of Illness Index

Substances

Antibodies, Monoclonal, Humanized
secukinumab